LSL.M. Syzova

L.M. Syzova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


L.M. Syzova has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The relevance of the human papillomavirus problem at the present stage

    by V.I. Ilchenko, M.A. Kiziun, L.M. Syzova, M.M. Ilchenko, O.M. Ketova, В.і. Ільченко

    Humam papillomavirus (HPV) is one of the most common sexually transmitted pathogens. The virus may not manifest itself for years, so a person does not even know that he is infected. The pathogen spreads, affects the partner and is transmitted further along the chain.The problem is that HPV can cause background precancerous and cancerous diseases in both women and men. The population is interested in methods of prevention of HPV infection in order to preserve their own life and health. But, as it turned out, there is insufficient sanitary and educational activity in Ukraine.HPV is one of the most dangerous enemies of human health. Ease of infection, low level of awareness, lack of vaccination – all this leads to oncological diseases of the reproductive system and, as a result, the reduction of the population of the nation. Cancer of the cervix, vagina, vulva, penis, anal canal is far from a complete list of oncological pathologies that threaten human life and health.And, despite the aggressiveness, these diseases can be easily prevented. It is enough only to carry out specific prevention, namely, to be vaccinated against HPV. This is not discussed, sanitary and educational activities are carried out at an inadequate level. Ukrainians want to know more, they are ready to get vaccinated. It is only important to give them such an opportunity.The article presents a detailed study of the problem of public awareness of HPV, analyzes the level of education of doctors and patients regarding HPV, the diseases it causes, methods of specific prevention to improve the health of the nation, describes the types of development and implementation of new methods and approaches to sanitary and educational activities and promotion of vaccination.Also provided is an analysis of data from worldwide and Ukrainian statistics on the prevalence of HPV, oncological diseases it causes, the level of vaccination, characteristics of vaccines, as well as an analysis of the results of randomized trials, data from preventive vaccination calendars in European countries.


  • Open Access

    Diabetes mellitus and COVID-19: living with double risk

    by O.V. Muravlova, Z.O. Shaienko, I.L. Dvornyk, L.M. Sizova, V.I. Ilchenko, T.I. Purdenko, O.A. Shpetnyi

    Background. The purpose is to analyze and summarize the studies conducted to determine the impact of COVID-19 on the course of diabetes mellitus and the manifestations of chronic complications of this disease. Materials and methods. We did the search in PubMed and ScienceDirect databases using the following line: “SARS-CoV-2 or COVID-19 and diabetes or hyperglycemia”. Results. It was found that in patients with diabetes, the severity of COVID-19 is increased. In particular, the number of those who needed intensive care or artificial ventilation has elevated. The same negative trend is noted for the overall mortality rate in patients with diabetes. It has been found that COVID-19 contributes to an increase in the development of diabetes, including diabetic ketoacidosis, hyperosmolar syndrome, brain stroke and mental health disorders, which can potentiate the effect of COVID-19 in enhancing the manifestations of diabetes and double risk for these patients. Along with this, the common pathways of the pathogenesis of diabetes and COVID-19 determine the bidirectionality of the interaction in their comorbidity. Conclusions. We have demonstrated numerous links between COVID-19 pathogenetic mechanisms and diabetes. Despite this, current research shows only modest evidence of an increased risk of metabolic, neurological, and psychiatric complications in patients with diabetes who had COVID-19. However, along with the direct impact of patients’ infection, the conditions of pandemic are also affected, which complicate access to the necessary care and should be taken into account when studying the clinical consequences of COVID-19 in patients with diabetes.


  • Open Access

    ЛЕПТОСПІРОЗ У ФОКУСІ СУЧАСНИХ ВИКЛИКІВ

    by Н. О. Прийменко, Т. І. Коваль, В. А. Боднар, Т. М. Котелевська, О. М. Ізюмська, Л. М. Сизова, О. Г. Марченко, В. А. Полторапавлов, Н. П. Лимаренко, О. І. Здор

    Розглянуто проблему лептоспірозу, який належить до найпоширеніших зоонозних захворювань у світі, що характеризується тяжким перебігом і високою летальністю. У світлі загроз, пов’язаних з війною в Україні та руйнуванням Каховської ГЕС, зросли ризики виникнення спалахів інфекційних захворювань, у тому числі й лептоспірозу. Детально охарактеризовані питання етіології, епідеміології, клінічного перебігу, лікування та профілактики захворювання. Наведено клінічний випадок тяжкого перебігу лептоспірозу у пацієнта молодого віку, спричиненого збудником серогрупи Іcterohaemorrhagiae.

  • Open Access

    ГАРЯЧКА НЕВІДОМОГО ПОХОДЖЕННЯ: АЛГОРИТМ ДІАГНОСТИКИ І ТАКТИКА ВЕДЕННЯ ПАЦІЄНТА

    by О. М. Ізюмська, Т. І. Коваль, О. Г. Марченко, Л. М. Сизова, В. А. Полторапавлов, Н. О. Прийменко, В. А. Боднар, Т. М. Котелевська, Н. П. Лимаренко, О. І. Здор

    Висвітлено сучасне визначення, класифікацію, основні причини гарячки невідомого походження (ГНП). Наведений алгоритм діагностичного пошуку, який складається з ретельного клініко-анамнестичного обстеження, рутинних лабораторних та інструментальних досліджень, що є основою первинної оцінки пацієнта з тривалою неуточненою гарячкою, а також призначення новітніх методів діагностики: лабораторних спеціальних для виключення інфекційних та автоімунних захворювань, неінвазивних та інвазивних інструментальних методів для діагностики онко-гематологічної та іншої патології. Розглянуті підходи до призначення емпіричної терапії пацієнтам з ГНП. Успішне вирішення проблеми диференційної діагностики цього стану залежить від конструктивної взаємодії багатьох спеціалістів (сімейних лікарів, інфекціоністів, ревматологів, гематологів, онкологів, хірургів), їх обізнаності із захворюваннями, які перебігають з тривалою неуточненою гарячкою, та розуміння тактики ведення пацієнтів.


  • Open Access

    The role of TLR-4 gene in the functioning of the natural human immune system and the immunopathogenesis of chronic hepatitis C (literature review)

    by T.I. Koval, L.M. Syzova, N.O. Pryimenko, A.н. Sydorenko, M.V. Kulіsh, V.I. Ilchenko, N.P. Lymarenko

    To date, despite significant advances in the study of the immunopathogenesis of chronic hepatitis C (CHC), many open questions remain in the diagnosis, prediction and course of treatment. In the context of the study of this infection, the Toll-like gene family of innate immune system receptors (TLRs) is of considerable interest. The article analyzes and summarizes the data of professional scientific sources on the role of the TLR-4 gene in the functioning of the natural human immune system, as well as Asp299Gly polymorphism of this gene in the immunopathogenesis of CHC. The relevance of the study is due to the fact that the innate immune system is crucial in the primary protection of the macroorganism from pathogens, the recognition of which largely depends on the TLRs receptor gene family, and genetic analysis is a modern and promising direction in personalized medicine. The importance of determining genetic markers lies in the fact that regardless of age and other factors of the external and internal environment, they carry information about the predisposition to various diseases, which can be used in the formation of a genetic passport. The data concerning the influence of the Asp299Gly polymorphism of the TLR4 gene on the immunopathogenesis of CHC are contradictory and require further investigation. An in-depth study of this issue will improve the therapeutic and diagnostic tactics of this disease based on a comprehensive assessment of the features of the immune response, which are caused by the carriage of the indicated polymorphism in the human genome.


    • 1 July 2016
      • p. 37-45

    CLINICAL AND GENETIC PREDICTORS AND PROGNOSTIC MODEL OF RAPIDLY PROGRESSIVE HEPATIC FIBROSIS IN CHRONIC HEPATITIS C.

    by G Dubinskaya, L Sizova, T Koval, Е Kovalyova, I Kaydashev

    The search for risk factors for rapid progression of hepatic fibrosis (HF) in chronic hepatitis C (CHC) is a topical scientific and practical task. The purpose of the study is to identify clinical and genetic predictors and create the prognostic model of rapidly progressive HF in CHC. A retrospective cohort study of 125 patients with CHC has been carried out. The logistic regression and ROC-analysis have been applied for statistical data processing. The resulting analysis of 46 potential predictors of rapidly progressive HF in CHC identified the following significant ctiteria: male gender - ОR=3.44 [95% СΙ 1.60-7.39], р=0.001; increased levels of alanine aminotransferase (ALT) - ОR=4.93 [95% СΙ 1.54-15.76], р=0.007, particularly, moderate cytolytic activity - ОR=2.36 [95% СΙ 1.08-5.16], р=0.031; aspartate aminotransferase (АSТ) - ОR=3.65 [95% СΙ 1.41-9.43] р=0.007; γ-glutamiltranspeptidase (GGTP) - ОR=3.63 [95% СΙ 1.73-7.61], р=0.001; total bilirubin - ОR=3.53 [95% СΙ 1.47-8.47], р=0.005; alkaline phosphatase - ОR=9.18 [95% 1.11-75.80], р=0.039; alcohol intake>40 g/day (ОR=3.53 [95% СΙ 1.36-9.17], р=0.009), Gln11Gln genotype of the TLR7 gene (ОR=4.56 [95% СΙ 1.57-13.22], р=0.005), presence of chronic cholecystitis and/or pancreatitis (ОR=5.30 [95% СΙ 1.84-15.25], р=0.002). The prognostic model, comprising 6 predictors (level of GGTP>upper limit of normal (ULN), male gender, Gln11Gln genotype of the TLR7 gene chronic cholecystitis and/or pancreatitis, levels of total bilirubin and АSТ>ULN) have been created, demonstrating the statistical significance (p=0.000) and high operational characteristics (sensitivity - 85.5%, specificity - 68.3%, total number of the appropriate assignments - 76.8%, positive and negative predictive value - 72,6% and 82.7%,, respectively, the AUC ROC-curve - 0.840). Use of the created model will help to predict the rapid progression of HF in CHC and form the risk-group, requiring individual approaches to prescribing antiviral therapy for CHC.

    • 1 January 2016
      • No. 250,p. 51-6

    [THE ROLE OF GENETIC POLYMORPHISMS TOLL-LIKE RECEPTOR 4 AND 7 IN THE CHRONIC HEPATITIS C AND GENDER FEATURES OF THEIR DISTRIBUTION].

    by Liudmyla Sizova, Tetiana Koval, Igor Kaidashev, V Ilchenko, G Dubinskaya

    The aim of the study was to investigate the prevalence of polymorphisms Asp299Gly (rs4986790) TLR4 gene and Gln11Leu (rs179008) TLR7 gene in patients with chronic hepatitis C in general and in gender distribution. To achieve this goal the study using the methods of "case-control", which included 125 patients with chronic hepatitis C who were treated in the Poltava Regional Clinical Hospital of Infectious Diseases. The group of population control for the study of the prevalence of polymorphisms Asp299Gly TLR4 gene included 90 healthy residents of the Poltava region, for Gln11Leu gene TLR7 - 85. Gender groups were equivalent. The study found that in patients with chronic hepatitis C genotype Asp299Gly TLR4 gene was detected in 15.2%, allele 299Gly - in 7.6%, which is 4.5-4.6 times higher than their rate in control group (3.3% and 1.7%, respectively, p0.05). "Mutant" genotypes of the TLR7 gene were determined significantly more often in women with chronic hepatitis C (27.1%) and in healthy people (39.5%) comparing to men (13.0% and 14.9%, respectively, p<0.05).